share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J

AbbVie | 4: Statement of changes in beneficial ownership of securities

艾伯维公司 | 4:持股变动声明
SEC announcement ·  04/02 17:07
Moomoo AI 已提取核心信息
Edward J. Rapp, a reporting person for AbbVie Inc. [ABBV], has been involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Edward J. Rapp to AbbVie Inc. was not specified, and there was no information provided regarding the number of shares held by Rapp after the transaction.
Edward J. Rapp, a reporting person for AbbVie Inc. [ABBV], has been involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Edward J. Rapp to AbbVie Inc. was not specified, and there was no information provided regarding the number of shares held by Rapp after the transaction.
艾伯维公司 [ABBV] 的举报人爱德华·拉普于2024年3月31日参与了该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。没有具体说明爱德华·拉普与艾伯维公司的关系,也没有提供有关拉普在交易后持有的股票数量的信息。
艾伯维公司 [ABBV] 的举报人爱德华·拉普于2024年3月31日参与了该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。没有具体说明爱德华·拉普与艾伯维公司的关系,也没有提供有关拉普在交易后持有的股票数量的信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息